Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
- Conditions
- Gastric Diseases,Gastric Ulcer,Early Gastric Cancer,Chronic GastritisGastric Polyps,
- Interventions
- Device: MCEDevice: Standard gastroscopy
- Registration Number
- NCT02219529
- Lead Sponsor
- Changhai Hospital
- Brief Summary
A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of standard gastroscopy for gastric diseases in 70 patients with encouraging results (In Press). To further testify the diagnostic accuracy of MCE for both the diffuse and focal diseases in stomach, we performed this single-blinded multi-center prospective study compared MCE with gastroscopy in patients with gastric symptoms and indication for upper GI Endoscopy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 350
- Patients presented with gastric symptoms and ready for the first Upper GI endoscopy
- Patients with known focal gastric diseases: gastric ulcer, gastric polyps, early gastric cancer, gastric stromal tumors and so on.
- Age of 18 years to 70 years
- Patients with impaired bowel movement from ileus or organic digestive diseases
- Patients with known large and obstructing tumors of the upper GI tract
- Patients after upper GI surgery or abdominal surgery altering GI anatomy
- Patients under full anticoagulation
- Patient in poor general condition
- Patients using equipment that may be affected by radio transmission
- Patients using equipment that may be affected by magnetic field
- Pregnancy or suspected pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MCE MCE patients were assigned to swallow MCE first, followed by the gastroscopy Standard gastroscopy Standard gastroscopy patients were assigned to swallow MCE first, followed by the gastroscopy
- Primary Outcome Measures
Name Time Method Number of subjects diagnosed with gastric diffuse lesions by MCE Versus Standard Gastroscopy 2 days Number of gastric focal lesions founded by MCE Versus Standard Gastroscopy 2 days
- Secondary Outcome Measures
Name Time Method Volume of water and drugs used for gastric preparation 1 hour Scores of the cleanliness of stomach after preparation 1 day Percentage of patients in whom there was complete visualization of the gastric surface in the antrum, body, and fundus and identification of the cardia and pylorus 1 day Examination times of MCE and standard gastroscopy 1 day Patient acceptance of MCE and standard gastroscopy 3 days Adverse events of both procedures 2 weeks
Trial Locations
- Locations (1)
Shanghai Changhai Hospital
🇨🇳Shanghai, China